{"entity":{"type":"insider","cik":"0001513697","url":"/insider/0001513697","json_url":"/insider/0001513697.json","name":"FERRARI LOUIS","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":8,"first":"2011-11-22","last":"2013-05-23","span_basis":"filed_date"},"name_variants":[{"name":"FERRARI LOUIS","source":"filing","n_filings":8,"first_seen":"2011-11-22","last_seen":"2013-05-23"}],"transactions":[{"id":5292080,"accession":"0001181431-13-030075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-030075","line_url":"/filing/0001181431-13-030075#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001513697","owner_name":"FERRARI LOUIS","owner_url":"/insider/0001513697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1020.0,"shares_display":"1,020","price_per_share":0.57,"price_display":"0.57","price_state":"stated","total_value":581.4,"total_display":"581.40","shares_owned_after":307439.0,"shares_owned_after_display":"307,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-22","filed_date":"2013-05-23","scope":"insider"},{"id":5019813,"accession":"0001181431-13-012262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-012262","line_url":"/filing/0001181431-13-012262#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001513697","owner_name":"FERRARI LOUIS","owner_url":"/insider/0001513697","role":"Director, Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":375.0,"shares_display":"375","price_per_share":0.99,"price_display":"0.99","price_state":"stated","total_value":371.25,"total_display":"371.25","shares_owned_after":295996.0,"shares_owned_after_display":"295,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-25","filed_date":"2013-02-25","scope":"insider"},{"id":4973673,"accession":"0001181431-13-007055","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-007055","line_url":"/filing/0001181431-13-007055#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001513697","owner_name":"FERRARI LOUIS","owner_url":"/insider/0001513697","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59000.0,"shares_display":"59,000","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":59590.0,"total_display":"59,590.00","shares_owned_after":299571.0,"shares_owned_after_display":"299,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-04","filed_date":"2013-02-06","scope":"insider"},{"id":4973667,"accession":"0001181431-13-007055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-007055","line_url":"/filing/0001181431-13-007055#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001513697","owner_name":"FERRARI LOUIS","owner_url":"/insider/0001513697","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3200.0,"shares_display":"3,200","price_per_share":1.02,"price_display":"1.02","price_state":"stated","total_value":3264.0,"total_display":"3,264.00","shares_owned_after":296371.0,"shares_owned_after_display":"296,371","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-04","filed_date":"2013-02-06","scope":"insider"},{"id":3313720,"accession":"0001181431-12-060647","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-12-060647","line_url":"/filing/0001181431-12-060647#line-4","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001513697","owner_name":"FERRARI LOUIS","owner_url":"/insider/0001513697","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":950.0,"shares_display":"950","price_per_share":1.16,"price_display":"1.16","price_state":"stated","total_value":1102.0,"total_display":"1,102.00","shares_owned_after":358571.0,"shares_owned_after_display":"358,571","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-26","filed_date":"2012-11-27","scope":"insider"},{"id":2089856,"accession":"0001181431-12-047424","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-047424","line_url":"/filing/0001181431-12-047424#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001513697","owner_name":"FERRARI LOUIS","owner_url":"/insider/0001513697","role":"Officer (President and CEO)","officer_title":"President and CEO","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":984.0,"shares_display":"984","price_per_share":1.002,"price_display":"1.00","price_state":"stated","total_value":985.968,"total_display":"985.97","shares_owned_after":348577.0,"shares_owned_after_display":"348,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-22","filed_date":"2012-08-24","scope":"insider"},{"id":3489814,"accession":"0001181431-12-031673","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-031673","line_url":"/filing/0001181431-12-031673#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001513697","owner_name":"FERRARI LOUIS","owner_url":"/insider/0001513697","role":"Officer (EVP, North American Commerical)","officer_title":"EVP, North American Commerical","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":942.0,"shares_display":"942","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":772.44,"total_display":"772.44","shares_owned_after":349561.0,"shares_owned_after_display":"349,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-22","filed_date":"2012-05-22","scope":"insider"},{"id":2608936,"accession":"0001181431-12-011054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-011054","line_url":"/filing/0001181431-12-011054#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001513697","owner_name":"FERRARI LOUIS","owner_url":"/insider/0001513697","role":"Officer (EVP, North American Commerical)","officer_title":"EVP, North American Commerical","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4100.0,"shares_display":"4,100","price_per_share":2.06,"price_display":"2.06","price_state":"stated","total_value":8446.0,"total_display":"8,446.00","shares_owned_after":350503.0,"shares_owned_after_display":"350,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-22","filed_date":"2012-02-23","scope":"insider"},{"id":9080377,"accession":"0001181431-11-057429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-057429","line_url":"/filing/0001181431-11-057429#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001513697","owner_name":"FERRARI LOUIS","owner_url":"/insider/0001513697","role":"Officer (SVP, North American Commerical)","officer_title":"SVP, North American Commerical","security_title":"Common Stock, $.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.29,"price_display":"2.29","price_state":"stated","total_value":9160.0,"total_display":"9,160.00","shares_owned_after":44000.0,"shares_owned_after_display":"44,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-21","filed_date":"2011-11-22","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000722104","name":"SAVIENT PHARMACEUTICALS INC","url":"/issuer/0000722104","role":"Director, Officer (President and CEO)","n_filings":8,"first_seen":"2011-11-22","last_seen":"2013-05-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001513697","retrieved_at":"2026-08-22T00:40:16+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}